Abstract: A disc brake device includes a rotary member, a brake disc, and an airflow-rate restriction member. The brake disc includes a disc body and a plurality of fins. The airflow-rate restriction member includes a base plate and a protruding portion. The base plate is sandwiched between the rotary member and the fins. The protruding portion is arranged inward in the radial direction of the disc body with respect to the fins. The protruding portion protrudes from the base plate toward a disc body side. The protruding portion extends in the circumferential direction of the disc body.

Abstract: A geranylgeranylacetamide compound having a piperazine ring represented by the following formula (I) ##STR1## wherein R represents a member selected from the class consisting of a hydrogen atom, C.sub.1 -C.sub.5 alkyl groups which are unsubstituted or mono-substituted by a halogen atom, C.sub.2 -C.sub.5 alkenyl groups and C.sub.7 -C.sub.8 aralkyl groups, R.sub.1 represents a C.sub.1 -C.sub.3 alkyl group, and n represents 0, 1 or 2,and a pharmaceutically acceptable acid addition salt thereof. The aforesaid compound can be prepared by reacting geranylgeranylacetic acid or its reactive derivative with a piperazine compound, and thereafter, if desired, transforming the free geranylgeranylacetamide compound thus obtained into its pharmaceutically acceptable acid addition salt. A pharmaceutical composition containing said compound exhibits antiulcerogenic activity, particularly excellent antipeptic ulcerogenic activity, and is useful as an agent for treating ulcers.